Fasting can meaningfully improve blood sugar control, particularly for people with type 2 diabetes or prediabetes. Clinical trials consistently show that various forms of intermittent fasting lower fasting blood glucose, reduce HbA1c (a measure of average blood sugar over three months), and improve how effectively your body uses insulin. The benefits aren’t just theoretical: in some studies, fasting protocols matched or outperformed standard diabetes medications for short-term glucose management.
How Fasting Improves Blood Sugar
When you go without food for an extended period, your insulin levels drop. That alone starts a chain of metabolic changes. Lower insulin activates a cellular energy sensor that promotes fuel efficiency and repair throughout your body. At the same time, your cells shift from growth mode into cleanup mode, a process called autophagy, where damaged components are broken down and recycled. These shifts collectively make your cells more responsive to insulin when you do eat again.
The practical result: your body needs less insulin to move the same amount of sugar out of your bloodstream. Over weeks and months, this improved insulin sensitivity translates into lower fasting glucose readings and a lower HbA1c. Weight loss amplifies the effect, since excess body fat, especially around the abdomen, is a major driver of insulin resistance.
What the Clinical Trials Show
The numbers from controlled studies are striking. A 12-week trial of 60 people with diabetes or prediabetes who followed a 10-hour eating window (fasting 14 hours per day) found a 15% reduction in fasting glucose and an 18% drop in HbA1c. The researchers noted this was nearly twice the impact of typical diabetes medication.
A randomized trial comparing two fasting schedules in 99 obese participants with type 2 diabetes found that both groups significantly outperformed the control group. Those on a 16:8 schedule (eating within 8 hours) saw fasting blood sugar drop by about 31 mg/dL over three months, while the 14:10 group (eating within 10 hours) saw a 28 mg/dL drop. The control group dropped only 9 mg/dL. HbA1c fell by roughly 0.5% in both fasting groups, compared to 0.2% in controls.
Perhaps the most provocative finding comes from a trial of 405 overweight Chinese adults with early type 2 diabetes. A 5:2 fasting plan (eating very low calories two days per week) reduced HbA1c by 1.9% over 16 weeks, compared to 1.6% for metformin and 1.5% for another common diabetes drug. The fasting group also lost significantly more weight: 9.7 kg versus 5.5 to 5.8 kg in the medication groups.
A broader systematic review of studies in people with impaired glucose metabolism confirmed the pattern. Intermittent fasting significantly lowered fasting blood glucose, HbA1c, insulin levels, and a key measure of insulin resistance called HOMA-IR.
Which Fasting Schedule Works Best
The two most studied approaches are time-restricted eating (like 16:8 or 14:10) and the 5:2 method, where you eat normally five days a week and restrict calories heavily on two days.
For blood sugar specifically, both approaches work. The 16:8 and 14:10 schedules produced nearly identical improvements in fasting glucose and HbA1c in head-to-head comparison. The 16:8 schedule did produce slightly more weight loss (4% of body weight versus 3.15% for 14:10 over 12 weeks), which could offer additional long-term metabolic benefits. Neither schedule caused serious side effects or hypoglycemia in the trial.
The 5:2 approach showed the most dramatic short-term results in the trial that compared it directly to diabetes medications, but it’s also more demanding. Two days of very low calorie intake each week requires planning and can be harder to sustain. For most people, a daily eating window of 8 to 10 hours is more practical as a long-term habit. The best schedule is the one you can maintain consistently.
What Happens to Blood Sugar Stability
One concern people have is whether fasting causes wild blood sugar swings. Data from continuous glucose monitors provides some reassurance. In studies tracking glucose variability during fasting versus non-fasting periods, the overall amplitude of blood sugar swings didn’t change significantly. People with diabetes who fasted spent less time with blood sugar above 180 mg/dL (the hyperglycemic range) compared to their non-fasting periods. Importantly, the time spent in hypoglycemia (dangerously low blood sugar) was similar during fasting and non-fasting periods across all groups studied, including those with diabetes.
In other words, fasting tends to trim the high spikes without increasing the dangerous lows, at least in the absence of certain medications.
Medication Risks During Fasting
This is where caution matters. If you take insulin, sulfonylureas, or meglitinides, fasting creates a real risk of hypoglycemia. These medications actively push blood sugar down regardless of whether you’ve eaten, so combining them with extended periods of no food can drop glucose to dangerous levels. The American Diabetes Association recommends that people at high risk for hypoglycemia have these medications reduced or switched to a lower-risk class before fasting.
If you take metformin or newer classes of diabetes drugs, the hypoglycemia risk during fasting is much lower. But any change to your eating pattern while on diabetes medication warrants a conversation with whoever prescribes your medication, ideally before you start.
The ADA’s 2025 standards also added specific recommendations for religious fasting, such as during Ramadan, including a formal risk assessment tool to help stratify who can fast safely and who needs medication adjustments first.
Who Benefits Most
The strongest evidence for fasting and blood sugar improvement exists in people with type 2 diabetes, prediabetes, or obesity with insulin resistance. These are the groups where insulin sensitivity is already impaired and where fasting’s metabolic reset has the most room to make a difference. The weight loss that typically accompanies fasting, often 3 to 4% of body weight within three months, directly reduces the fat deposits that drive insulin resistance.
For people with normal blood sugar and no insulin resistance, fasting still produces the same metabolic shifts, but the practical benefit is smaller since your glucose regulation is already working well. The effect is most noticeable when there’s a problem to fix.
People with type 1 diabetes face a fundamentally different situation. Because type 1 involves an inability to produce insulin rather than resistance to it, fasting carries higher risks and the evidence for benefit is much thinner. The medication-related hypoglycemia risk is also substantially greater in type 1.